Debt-to-Equity Ratio

Zimmer Biomet's debt-to-equity ratio of 0.59x means the company uses $0.59 of debt for every $1.00 of shareholders' equity, a standard measure of financial leverage.

That ratio sits above the healthcare sector median of 0.43x, placing Zimmer Biomet in the 57th percentile among peers—indicating it carries more debt than most comparable firms. Year-over-year change is not available, but the ratio rose 15.7% quarter-over-quarter from 0.51x to 0.59x, based on the two most recent historical values. The combination of a debt level already above the sector median and a sharp quarterly increase suggests higher financial risk, as the company is relying more on borrowed funds. This trend could limit financial flexibility if interest costs rise or cash flow tightens, presenting a modest downside risk for investors. However, a ratio of 0.59x is not alarming in absolute terms and does not contradict the overall NEUTRAL verdict—it supports a balanced view, as the leverage is manageable but warrants monitoring given the recent uptick.

Frequently Asked Questions

Closest Sector Peers